An in vitro system to silence mitochondrial gene expression.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
11 11 2021
Historique:
received: 11 05 2021
revised: 10 09 2021
accepted: 24 09 2021
pubmed: 22 10 2021
medline: 7 1 2022
entrez: 21 10 2021
Statut: ppublish

Résumé

The human mitochondrial genome encodes thirteen core subunits of the oxidative phosphorylation system, and defects in mitochondrial gene expression lead to severe neuromuscular disorders. However, the mechanisms of mitochondrial gene expression remain poorly understood due to a lack of experimental approaches to analyze these processes. Here, we present an in vitro system to silence translation in purified mitochondria. In vitro import of chemically synthesized precursor-morpholino hybrids allows us to target translation of individual mitochondrial mRNAs. By applying this approach, we conclude that the bicistronic, overlapping ATP8/ATP6 transcript is translated through a single ribosome/mRNA engagement. We show that recruitment of COX1 assembly factors to translating ribosomes depends on nascent chain formation. By defining mRNA-specific interactomes for COX1 and COX2, we reveal an unexpected function of the cytosolic oncofetal IGF2BP1, an RNA-binding protein, in mitochondrial translation. Our data provide insight into mitochondrial translation and innovative strategies to investigate mitochondrial gene expression.

Identifiants

pubmed: 34672953
pii: S0092-8674(21)01116-8
doi: 10.1016/j.cell.2021.09.033
pii:
doi:

Substances chimiques

IGF2BP1 protein, human 0
Mitochondrial Proteins 0
Oligonucleotides 0
Protein Subunits 0
RNA, Messenger 0
RNA, Mitochondrial 0
RNA-Binding Proteins 0
Electron Transport Complex IV EC 1.9.3.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5824-5837.e15

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no conflict of interest.

Auteurs

Luis Daniel Cruz-Zaragoza (LD)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Sven Dennerlein (S)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Andreas Linden (A)

Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; Department of Clinical Chemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Roya Yousefi (R)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Elena Lavdovskaia (E)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany; Cluster of Excellence, Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells (MBExC), University of Göttingen, Göttingen, Germany.

Abhishek Aich (A)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany; Cluster of Excellence, Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells (MBExC), University of Göttingen, Göttingen, Germany.

Rebecca R Falk (RR)

Department of Molecular Biology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Ridhima Gomkale (R)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Thomas Schöndorf (T)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Markus T Bohnsack (MT)

Department of Molecular Biology, University Medical Center Göttingen, 37073 Göttingen, Germany; Cluster of Excellence, Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells (MBExC), University of Göttingen, Göttingen, Germany.

Ricarda Richter-Dennerlein (R)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany; Cluster of Excellence, Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells (MBExC), University of Göttingen, Göttingen, Germany.

Henning Urlaub (H)

Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; Department of Clinical Chemistry, University Medical Center Göttingen, 37073 Göttingen, Germany.

Peter Rehling (P)

Department of Cellular Biochemistry, University Medical Center Göttingen, 37073 Göttingen, Germany; Cluster of Excellence, Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells (MBExC), University of Göttingen, Göttingen, Germany; Max Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany. Electronic address: peter.rehling@medizin.uni-goettingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH